نتایج جستجو برای: soluble fas ligand

تعداد نتایج: 201321  

Journal: :Journal of immunology 2002
Xiaochun Wan Jun Zhang Hongyu Luo Guixiu Shi Elena Kapnik Sunghee Kim Palanisamy Kanakaraj Jiangping Wu

DcR3/TR6 is a secreted protein belonging to the TNFR family. It binds to Fas ligand, LIGHT, and TL1A, all of which are TNF family members. LIGHT is expressed on activated T cells. Its known receptors are TR2 and LTbetaR on the cell surface, and TR6 in solution. In the present study, we report soluble TR6-Fc or solid-phase TR6-Fc costimulated proliferation, lymphokine production, and cytotoxicit...

Journal: :Clinical chemistry 2000
N Chanarat P Chanarat D Chiewsilp

To the Editor: In HIV infection, the mechanism of destruction of the CD41 T cells is unknown. Apoptosis may play an important role in the pathogenesis of HIV. One apoptotic pathway is mediated through the Fas-Fas ligand pathway. Soluble Fas (sFas) in serum is thought to act as an inhibitor of Fas-Fas ligand binding and to block Fas-mediated apoptosis (1 ). We studied the role of sFas as a marke...

Journal: :Blood 1998
C H Dai J O Price T Brunner S B Krantz

Interferon gamma (IFNgamma) inhibits the growth and differentiation of highly purified human erythroid colony-forming cells (ECFCs) and induces erythroblast apoptosis. These effects are dose- and time-dependent. Because the cell surface receptor known as Fas (APO-1; CD95) triggers programmed cell death after activation by its ligand and because incubation of human ECFCs with IFNgamma produces a...

1998
Chun-Hua Dai James O. Price Thomas Brunner

Interferon g (IFNg) inhibits the growth and differentiation of highly purified human erythroid colony-forming cells (ECFCs) and induces erythroblast apoptosis. These effects are doseand time-dependent. Because the cell surface receptor known as Fas (APO-1; CD95) triggers programmed cell death after activation by its ligand and because incubation of human ECFCs with IFNg produces apoptosis, we h...

Journal: :Blood 2006
Edwin Bremer Bram ten Cate Douwe F Samplonius Lou F M H de Leij Wijnand Helfrich

Agonistic anti-Fas antibodies and multimeric recombinant Fas ligand (FasL) preparations show high tumoricidal activity against leukemic cells, but are unsuitable for clinical application due to unacceptable systemic toxicity. Consequently, new antileukemia strategies based on Fas activation have to meet the criterion of strictly localized action at the tumor-cell surface. Recent insight into th...

2002
Steven D. Webb Jonathan A. Sherratt Reginald G. Fish

One proposed mechanism of tumour escape from immune surveillance is tumour up-regulation of the cell surface ligand FasL, which can lead to apoptosis of Fas receptor (Fas) positive lymphocytes. Based upon this ‘counterattack’, we have developed a mathematical model involving tumour cell–lymphocyte interaction, cell surface expression of Fas/FasL, and their secreted soluble forms. The model pred...

Journal: :The Journal of Experimental Medicine 1996
W C Liles P A Kiener J A Ledbetter A Aruffo S J Klebanoff

Human neutrophils, monocytes, and eosinophils are known to undergo apoptotic cell death. The Fas/Fas ligand pathway has been implicated as an important cellular pathway mediating apoptosis in diverse cell types. We conducted studies to examine the importance of the Fas/FasL system in normal human phagocytes. Although Fas expression was detected on neutrophils, monocytes, and eosinophils, consti...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید